An increased risk of breast or ovarian cancer is associated with monoallelic mutations in a subset of these genes (BRCA1, BRCA2, BRIP1, PALB2, RAD51C) [15–20]. The gene discussed is BRCA1; the disease is ovarian carcinoma.